Individuals Discontinuing Slimming Injections Put On Pounds Far More Rapidly Than People Using Diet and Exercise
A recent study reveals that people who discontinue popular slimming jabs like semaglutide or tirzepatide can put back on reduced body mass much more quickly than those who stop traditional lifestyle plans.
Research printed in a prominent health publication shows that while overweight individuals frequently drop a large proportion of their body weight while on the medication, the weight is regained at an average rate of 0.8 kg per month after stopping.
"Users purchasing such medications should be informed of the risk of quick rebound weight gain when the therapy concludes," warns lead investigator Dr. Susan Jebb.
This pace of regain suggests a return to original mass within about a year and a half.
Analyzing Treatments
The study, which looked at dozens of trials involving thousands of patients, contrasted the effects of the injectable medications with conventional dieting.
Researchers point out that people who lose weight through lifestyle changes alone usually have a more gradual creep back—around 0.1 kg a month—after stopping.
Understanding the Fast Rebound
Nutrition scientists propose the mode of action of the jabs is key to understanding the accelerated weight return.
These medications copy a body's own chemical called GLP-1, which moderates appetite.
"Long-term administration of the hormone concentrations far above than normal might result in the system to generate a reduced amount of its own natural hormone, and could diminish sensitivity to its effects," explained Dr. Adam Collins, a nutrition specialist.
"Withdrawal of this medication leads to appetite is no longer kept in check, making excessive eating a significant risk."
A Lifelong Condition?
The NHS suggest the injections for people with weight-linked health risks, accompanied by prescribed diet and exercise modifications.
Many experts say that, considering the likelihood of relapse, the treatment might need to be life-long.
This view is reinforced by drug manufacturers, who note that the results "highlight the chronic nature of excess weight," comparing it to managing conditions like diabetes.
User Experiences
Individuals who have stopped the jabs report a intense return of appetite.
"It was like a trigger flipping and you're instantly starving," said one woman.
The struggle is worsened if individuals have not developed permanent lifestyle or habit changes during therapy.
Growing Adoption
Figures suggest that a significant number of people in the UK have tried these injections in the last 12 months, with desire remaining high.
- Use is more common among women than males.
- The 40s and 50s demographic shows the highest usage rates.
- A large proportion access the drugs through private healthcare rather than public health services.
In conclusion, researchers stress that while these medications are powerful tools for shedding pounds, they are not a standalone solution and long-term success relies on ongoing lifestyle support.
